|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - VIA Pharmaceuticals Inc. (VIAP)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
VIA Pharmaceuticals Inc: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-12-05 Purchase |
2008-12-19 4:07 pm | VIA Pharmaceuticals, Inc. | VIAP | Taub Rebecca (SVP, Research & Development) | 32,500 | $0.3 | $9,750 | 32,500 (Direct) | View |
| 2007-11-05- -2007-11-06 Sale | 2007-11-07 6:31 pm |
VIA Pharmaceuticals, Inc. | VIAP | Flynn James E DEERFIELD CAPITAL LP Deerfield Special Situations Fund, L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund International LTD (Possible Member of 10% Group 10% owner) | 63,238 | $3.21 | $203,010 | 1,244,708 (Indirect) | View |
| 2007-10-31 Sale |
2007-11-02 6:58 pm |
VIA Pharmaceuticals, Inc. | VIAP | Flynn James E DEERFIELD CAPITAL LP Deerfield Special Situations Fund, L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund International LTD (Possible Member of 10% Group 10% owner) | 116 | $3.965 | $460 | 1,284,676 (Indirect) | View |
| 2007-10-26 Sale | 2007-10-30 7:27 pm |
VIA Pharmaceuticals, Inc. | VIAP | Flynn James E DEERFIELD CAPITAL LP Deerfield Special Situations Fund, L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund International LTD (Possible Member of 10% Group 10% owner) | 2,307 | $3.924 | $9,052 | 1,284,750 (Indirect) |
View |
| 2007-10-22- -2007-10-25 Sale |
2007-10-26 10:13 am | VIA Pharmaceuticals, Inc. | VIAP | Flynn James E DEERFIELD CAPITAL LP Deerfield Special Situations Fund, L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund International LTD (10% owner) | 16,120 | $3.913 | $63,070 | 1,286,209 (Indirect) |
View |
| 2007-10-17- -2007-10-18 Sale | 2007-10-19 8:05 pm |
VIA Pharmaceuticals, Inc. | VIAP | Flynn James E DEERFIELD CAPITAL LP Deerfield Special Situations Fund, L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund International LTD (10% owner) | 6,345 | $4.019 | $25,499 | 1,296,399 (Indirect) |
View |
| 2007-08-08 Purchase | 2007-08-10 1:27 pm | VIA Pharmaceuticals, Inc. | VIAP | ANDERSON RICHARD L (Director) | 10,000 | $2.43 | $24,300 | 10,000 (Direct) |
View |
| 2004-05-07 Purchase | 2004-05-11 4:16 pm | CORAUTUS GENETICS INC | CAQ | MERRIMAN RONALD (Director) | 1,500 | $5.5 | $8,250 | 1,500 (Direct) | View |
Other transactions:
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2008-12-17 Option Award |
2008-12-19 4:07 pm |
VIA Pharmaceuticals, Inc. | VIAP | Taub Rebecca (SVP, Research & Development) | 125,000 | $0 | $0 | 157,500 (Direct) |
View |
| 2008-12-17 Option Award | 2008-12-19 4:05 pm | VIA Pharmaceuticals, Inc. | VIAP | Stewart James Gordon (SVP, CFO and Secretary) | 125,000 | $0 | $0 | 217,930 (Direct) | View |
| 2008-12-17 Option Award |
2008-12-19 4:04 pm | VIA Pharmaceuticals, Inc. | VIAP | Cohen Lawrence Kenneth (CEO and President Director) | 300,000 | $0 | $0 | 419,660 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date | Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2009-03-12 Purchase |
2009-03-16 6:04 pm |
2009-03-12 2014-03-12 | VIA Pharmaceuticals, Inc. | VIAP | GIVEN DOUGLAS B (Director) | 23,819 | $0.12 | 23,819 (Indirect) |
View |
| 2009-03-12 Purchase |
2009-03-16 6:02 pm | 2009-03-12 2014-03-12 |
VIA Pharmaceuticals, Inc. | VIAP | CRAVES FRED B (Director) | 7,241,618 | $0.12 | 7,241,618 (Indirect) | View |
| 2009-03-12 Purchase |
2009-03-16 6:02 pm | 2009-03-12 2014-03-12 |
VIA Pharmaceuticals, Inc. | VIAP | CRAVES FRED B (Director) | 119,308 | $0.12 | 119,308 (Indirect) | View |
| 2009-03-12 Purchase | 2009-03-13 1:57 pm | 2009-03-12 2014-03-12 | VIA Pharmaceuticals, Inc. | VIAP | BAY CITY CAPITAL LLC Bay City Capital Fund IV, L.P. Bay City Capital Management IV LLC BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (10% owner) | 81,575,000 | $0.12 | 81,575,000 (Direct) | View |
| 2009-03-12 Purchase | 2009-03-13 1:57 pm |
2009-03-12 2014-03-12 | VIA Pharmaceuticals, Inc. | VIAP | BAY CITY CAPITAL LLC Bay City Capital Fund IV, L.P. Bay City Capital Management IV LLC BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (10% owner) | 1,758,333 | $0.12 | 1,758,333 (Direct) | View |
| 2009-03-12 Purchase | 2009-03-13 1:57 pm |
2009-03-12 2014-03-12 |
VIA Pharmaceuticals, Inc. | VIAP | BAY CITY CAPITAL LLC Bay City Capital Fund IV, L.P. Bay City Capital Management IV LLC BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (10% owner) | 16,315,000 | $0.12 | 16,315,000 (Indirect) | View |
| 2009-03-12 Purchase | 2009-03-13 1:57 pm | 2009-03-12 2014-03-12 |
VIA Pharmaceuticals, Inc. | VIAP | BAY CITY CAPITAL LLC Bay City Capital Fund IV, L.P. Bay City Capital Management IV LLC BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (10% owner) | 295,690 | $0.12 | 295,690 (Indirect) | View |
| 2009-03-12 Purchase | 2009-03-13 1:57 pm | 2009-03-12 2014-03-12 |
VIA Pharmaceuticals, Inc. | VIAP | BAY CITY CAPITAL LLC Bay City Capital Fund IV, L.P. Bay City Capital Management IV LLC BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (10% owner) | 3,263,000 | $0.12 | 3,263,000 (Indirect) | View |
| 2009-03-12 Purchase | 2009-03-13 1:57 pm |
2009-03-12 2014-03-12 |
VIA Pharmaceuticals, Inc. | VIAP | BAY CITY CAPITAL LLC Bay City Capital Fund IV, L.P. Bay City Capital Management IV LLC BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (10% owner) | 59,138 | $0.12 | 59,138 (Indirect) | View |
| 2008-12-17 Option Award |
2008-12-19 4:02 pm |
2008-12-17 2018-12-17 |
VIA Pharmaceuticals, Inc. | VIAP | LARSON JOHN RANDOLPH (Director) | 10,000 | $0.15 | 10,000 (Direct) | View |
| 2008-12-17 Option Award |
2008-12-19 4:00 pm | 2008-12-17 2018-12-17 | VIA Pharmaceuticals, Inc. | VIAP | HOWARD DAVID T (Director) | 10,000 | $0.15 | 10,000 (Direct) | View |
| 2008-12-17 Option Award |
2008-12-19 3:58 pm |
2008-12-17 2018-12-17 | VIA Pharmaceuticals, Inc. | VIAP | Bagnall Mark (Director) | 10,000 | $0.15 | 10,000 (Direct) | View |
| 2008-12-17 Option Award |
2008-12-19 3:55 pm | 2008-12-17 2018-12-17 | VIA Pharmaceuticals, Inc. | VIAP | ANDERSON RICHARD L (Director) | 10,000 | $0.15 | 10,000 (Direct) | View |
| 2008-01-15 Option Award |
2008-01-16 12:03 pm |
N/A 2018-01-15 |
VIA Pharmaceuticals, Inc. | VIAP | Taub Rebecca (SVP, Research & Development) | 235,000 | $2.9 | 235,000 (Direct) |
View |
| 2007-12-17 Option Award | 2007-12-19 12:31 pm |
N/A 2017-12-17 | VIA Pharmaceuticals, Inc. | VIAP | Stewart James Gordon (SVP, CFO and Secretary) | 310,000 | $2.38 | 310,000 (Direct) |
View |
| 2007-12-17 Option Award |
2007-12-19 12:30 pm | N/A 2017-12-17 | VIA Pharmaceuticals, Inc. | VIAP | OLUKOTUN ADEOYE Y (Chief Medical Officer) | 120,000 | $2.38 | 120,000 (Direct) |
View |
| 2007-12-17 Option Award |
2007-12-19 12:30 pm | 2007-12-17 2017-12-17 | VIA Pharmaceuticals, Inc. | VIAP | LARSON JOHN RANDOLPH (Director) | 20,000 | $2.38 | 20,000 (Direct) | View |
| 2007-12-17 Option Award |
2007-12-19 12:29 pm |
2007-12-17 2017-12-17 | VIA Pharmaceuticals, Inc. | VIAP | HOWARD DAVID T (Director) | 20,000 | $2.38 | 20,000 (Direct) |
View |
| 2007-12-17 Option Award | 2007-12-19 12:28 pm | N/A 2017-12-17 |
VIA Pharmaceuticals, Inc. | VIAP | Cohen Lawrence Kenneth (CEO and President Director) | 600,000 | $2.38 | 600,000 (Direct) |
View |
| 2007-12-17 Option Award |
2007-12-19 12:26 pm | 2007-12-17 2017-12-17 |
VIA Pharmaceuticals, Inc. | VIAP | Bagnall Mark (Director) | 20,000 | $2.38 | 20,000 (Direct) | View |
| 2007-12-17 Option Award | 2007-12-19 12:26 pm | 2007-12-17 2017-12-17 |
VIA Pharmaceuticals, Inc. | VIAP | ANDERSON RICHARD L (Director) | 20,000 | $2.38 | 20,000 (Direct) | View |
| 2006-06-21 Option Award | 2006-06-23 2:41 pm | N/A 2016-06-21 | CORAUTUS GENETICS INC | VEGF | OTTO RICHARD E (Chief Executive Officer Director) | 200,000 | $0.75 | 200,000 (Direct) | View |
| 2006-06-21 Option Award | 2006-06-23 2:41 pm |
N/A 2016-06-21 | CORAUTUS GENETICS INC | VEGF | ATWOOD ROBERT T (CFO, Executive VP Director) | 200,000 | $0.75 | 200,000 (Direct) |
View |
| 2006-05-15 Option Award | 2006-05-15 6:39 pm |
N/A 2016-05-15 |
CORAUTUS GENETICS INC | VEGF | Steele Michael K (VP - Business Development) | 60,000 | $0.85 | 60,000 (Direct) |
View |
| 2006-05-15 Option Award | 2006-05-15 6:39 pm |
N/A 2016-05-15 | CORAUTUS GENETICS INC | VEGF | CHIANG YAWEN L (SVP - Chief Scientific Officer) | 100,000 | $0.85 | 100,000 (Direct) |
View |
| 2006-05-15 Option Award | 2006-05-15 6:39 pm | N/A 2016-05-15 |
CORAUTUS GENETICS INC | VEGF | CALLICUTT JACK W (VP-Finance&Admin, Chf Acct Off) | 80,000 | $0.85 | 80,000 (Direct) |
View |
| 2006-05-11 Option Award |
2006-05-15 6:37 pm |
N/A 2016-05-11 | CORAUTUS GENETICS INC | VEGF | SCHMITT VICTOR W (Director) | 87,769 | $0.85 | 87,769 (Direct) | View |
| 2006-05-11 Option Award |
2006-05-15 6:37 pm |
N/A 2016-05-11 | CORAUTUS GENETICS INC | VEGF | ROYSTON IVOR (Director) | 87,769 | $0.85 | 87,769 (Direct) |
View |
| 2006-05-11 Option Award | 2006-05-15 6:36 pm |
N/A 2016-05-11 |
CORAUTUS GENETICS INC | VEGF | PARSHALL B LYNNE (Director) | 114,554 | $0.85 | 114,554 (Direct) |
View |
| 2006-05-11 Option Award |
2006-05-15 6:36 pm |
N/A 2016-05-11 | CORAUTUS GENETICS INC | VEGF | NICHOL F RICHARD PHD (Director) | 99,169 | $0.85 | 99,169 (Direct) | View |
| 2006-05-11 Option Award | 2006-05-15 6:36 pm |
N/A 2016-05-11 |
CORAUTUS GENETICS INC | VEGF | FALKENBERG ERIC N (Director) | 118,261 | $0.85 | 118,261 (Direct) |
View |
| 2006-05-11 Option Award |
2006-05-15 6:34 pm |
N/A 2016-05-11 |
CORAUTUS GENETICS INC | VEGF | GILSTRAP JAMES C (Director) | 114,554 | $0.85 | 114,554 (Direct) | View |
| 2004-09-27 Option Award | 2004-09-27 12:41 pm | N/A 2014-09-26 |
CORAUTUS GENETICS INC | CAQ | Russell Gayle (Sr VP - Clinical & Regulatory) | 20,000 | $5.27 | 20,000 (Direct) | View |
| 2004-05-07 Option Award | 2004-05-11 4:16 pm | 2004-05-07 2014-05-07 | CORAUTUS GENETICS INC | CAQ | MERRIMAN RONALD (Director) | 24,000 | $5.5 | 24,000 (Direct) | View |
| 2004-05-07 Option Award | 2004-05-11 4:16 pm |
N/A 2014-05-07 | CORAUTUS GENETICS INC | CAQ | MERRIMAN RONALD (Director) | 15,000 | $5.5 | 15,000 (Direct) | View |
| 2004-04-15 Option Award |
2004-04-19 5:25 pm | 2004-04-15 2014-04-15 | CORAUTUS GENETICS INC | CAQ | QUADROS PAUL D (Director) | 1,500 | $6 | 1,500 (Direct) | View |
| 2004-04-15 Option Sale |
2004-04-19 5:25 pm | N/A 2004-05-04 |
CORAUTUS GENETICS INC | CAQ | QUADROS PAUL D (Director) | 11,700 | $2.24 | 0 (Direct) | View |
| 2004-04-15 Option Award |
2004-04-19 5:25 pm | N/A 2005-02-05 | CORAUTUS GENETICS INC | CAQ | QUADROS PAUL D (Director) | 11,700 | $2.24 | 11,700 (Direct) | View |
| 2004-04-15 Option Sale |
2004-04-19 5:25 pm |
N/A 2004-05-04 | CORAUTUS GENETICS INC | CAQ | QUADROS PAUL D (Director) | 6,844 | $45.5 | 0 (Direct) | View |
| 2004-04-15 Option Award | 2004-04-19 5:25 pm |
N/A 2005-02-05 |
CORAUTUS GENETICS INC | CAQ | QUADROS PAUL D (Director) | 6,844 | $45.5 | 6,844 (Direct) | View |
| 2004-04-15 Option Award |
2004-04-19 5:25 pm |
2004-04-15 2014-04-15 |
CORAUTUS GENETICS INC | CAQ | PHARAND DANIEL (Director) | 2,000 | $6 | 2,000 (Direct) |
View |
| 2003-10-13 Option Award |
2003-10-15 11:02 am | 2003-10-13 2013-10-13 | CORAUTUS GENETICS INC | CAQ | SEWELL NINA VINCENT (Sr VP - Clinical & Regulatory) | 50,000 | $4.78 | 50,000 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 23:09:52 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |